Please read and agree to the terms and conditions of this site.
@xconomy.com 3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com 4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com 4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@techcrunch.com 4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@xconomy.com 5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President